Article
Pluripotent stem cell-derived siTNK cells attack tumors via a synthetic CD8-CD28-TCR complex
2025-07-12
Abstract excerpt
<h4>SUMMARY</h4> Tumor-associated antigen-specific T cell receptor (TCR)-engineered T cells offer a promising strategy for cancer therapy. Natural killer (NK) cells exhibit broad anti-tumor activity with low side effects but lack the capacity to recognize intracellular antigens. Here, we found that the human pluripotent stem cell (hPSC)-derived iNK cells, unlike tissue-isolated NK cells, expressed all four CD3 su...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 043c7578-eaf0-5ac6-8f67-8c1c9492b622
- DOI
- 10.1101/2025.07.11.663392
